As cancer develops, at least two cell processes are disrupted — cell growth is promoted, and cell death inhibited. It seems that mutated versions of the notorious cancer-promoting protein MYC can accomplish both at once.
This is a preview of subscription content, access via your institution
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Hemann, M. T. et al. Nature 436, 807–811 (2005).
Chang, D. W., Claassen, G. F., Hann, S. R. & Cole, M. D. Mol. Cell. Biol. 20, 4309–4319 (2000).
Egle, A., Harris, A. W., Bouillet, P. & Cory, S. Proc. Natl Acad. Sci. USA 101, 6164–6169 (2004).
Wu, S. et al. Oncogene 22, 351–360 (2003).
Seoane, J., Le, H. V. & Massagué, J. Nature 419, 729–734 (2002).
Collins, N. L. et al. Mol. Cell. Biol. 25, 5282–5291 (2005).
Schmitt, C. A. et al. Cell 109, 335–346 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berns, A. Two in one. Nature 436, 787–789 (2005). https://doi.org/10.1038/436787a
Published:
Issue Date:
DOI: https://doi.org/10.1038/436787a